8-K: MetLife Reports Strong First Quarter 2024 Results, Announces $3 Billion Share Repurchase Program

MetLife's first quarter 2024 results show a significant increase in net income and adjusted earnings compared to the same period last year, alongside a new $3 billion share repurchase authorization.

Summary

• MetLife announced its first quarter 2024 results, reporting a net income of $800 million, or $1.10 per share, a substantial increase from $14 million, or $0.02 per share, in the first quarter of 2023.
• Adjusted earnings for the quarter were $1.3 billion, or $1.83 per share, up from $1.2 billion, or $1.52 per share, in the prior year.
• The company's book value per share decreased by 6 percent year-over-year to $34.54, while book value excluding accumulated other comprehensive income (AOCI) other than foreign currency translation adjustments (FCTA) decreased by 1 percent to $53.13.
• MetLife's return on equity (ROE) was 12.6 percent, and adjusted ROE, excluding AOCI other than FCTA, was 13.8 percent.
• Holding company cash and liquid assets stood at $5.2 billion as of March 31, 2024, exceeding the target cash buffer of $3.0 $4.0 billion.
• Premiums, fees, and other revenues totaled $12.0 billion, a 4 percent increase compared to the first quarter of 2023.
• Net investment income rose by 17 percent to $5.4 billion, driven by higher variable investment income and interest rates.
• The Board of Directors approved a new $3 billion authorization to repurchase the company's common stock.

Sentiment

Score: 8

Explanation: The document presents a strong financial performance with significant improvements in key metrics, a new share repurchase program, and positive management commentary. While there are some negative aspects, the overall tone is optimistic and indicates a positive outlook for the company.

Positives

• Net income and adjusted earnings showed substantial year-over-year growth.
• Net investment income saw a significant increase due to higher variable investment income and interest rates.
• The company's cash position is strong, exceeding the target buffer.
• The new share repurchase program indicates confidence in the company's financial position and future prospects.
• Adjusted earnings in Asia increased by 51 percent on a reported basis and 57 percent on a constant currency basis.
• Sales in the Group Benefits segment were up 25 percent.

Negatives

• Book value per share decreased by 6 percent year-over-year.
• Net derivative losses amounted to $979 million, largely driven by the U.S. dollar strengthening, higher equity markets and an increase in long-term interest rates.
• Adjusted earnings in the Group Benefits segment decreased by 7 percent due to lower non-medical health underwriting margins.
• Sales in Asia were down 8 percent on a constant currency basis.

Risks

• The document mentions risks related to economic conditions, global capital markets, credit ratings, reinsurance, regulatory changes, tax laws, litigation, and cybersecurity.
• The company's results are subject to market volatility, which can impact investment income and derivative gains/losses.
• Changes in interest rates and currency exchange rates can affect the company's financial performance.
• The company faces competition and technological changes that could impact its business.
• There are risks associated with product guarantees, risk management failures, and operational risks.

Future Outlook

The company's progress through consistent execution of its strategy positions it to drive further growth, creating long-term value for shareholders and other stakeholders. The document also includes forward-looking statements that are subject to risks and uncertainties.

Management Comments

• MetLife President and CEO Michel Khalaf stated that MetLife is off to a good start in 2024, with strong topline growth and sustained momentum across its market-leading portfolio of businesses.
• Michel Khalaf also noted that the progress made through consistent execution of their strategy positions them to drive further growth, creating long-term value for shareholders and other stakeholders.

Industry Context

This announcement reflects a positive start to the year for MetLife, aligning with broader trends of increased investment income due to higher interest rates. The company's focus on strategic execution and growth is consistent with industry-wide efforts to enhance shareholder value. The share repurchase program is a common strategy among large financial institutions to return capital to shareholders.

Comparison to Industry Standards

• MetLife's adjusted ROE of 13.8% is a strong result compared to industry averages, which typically range from 10-12% for large insurance companies.
• The 17% increase in net investment income is notable, as many insurers are benefiting from higher interest rates, but MetLife's growth is above average.
• The $3 billion share repurchase program is significant, indicating a strong capital position and confidence in future cash flows, similar to actions taken by peers like Prudential and Lincoln Financial.
• While book value per share declined, this is a common trend in the current market environment due to unrealized losses on fixed income securities, which is also affecting other large insurers like AIG and Allstate.
• MetLife's expense ratio of 20.5% is within the typical range for large insurance companies, but the company is focused on improving efficiency, as seen in the direct expense ratio of 11.9%.

Stakeholder Impact

• Shareholders will benefit from the increased profitability and the new share repurchase program.
• Employees may see positive impacts from the company's strong performance.
• Customers will continue to receive insurance and financial services from a financially stable company.
• Creditors will have confidence in the company's ability to meet its obligations.

Next Steps

• MetLife will hold its first quarter 2024 earnings conference call and audio webcast on Thursday, May 2, 2024.
• The company will continue to execute its strategy to drive further growth and create long-term value for shareholders.

Key Dates

Keywords

MetLife, Financial Results, Earnings, Share Repurchase, Net Income, Adjusted Earnings, Investment Income, Insurance, Premiums, ROE, AUM